`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`
`WATSON LABORATORIES, INC.
`Petitioner
`
`v.
`
`UNITED THERAPEUTICS CORP.
`Patent Owner
`
`
`
`Patent No. 9,339,507
`Issue Date: July 13, 2017
`Title: TREPROSTINIL ADMINISTRATION BY INHALATION
`_______________
`
`Inter Partes Review No. 2017-01622
`____________________________________________________________
`
`JOINT STIPULATION TO EXTEND TIME
`
`
`
`4824-8191-3696
`
`
`
`IPR2017-01622
`
`
`
`Joint Stipulation to Extend Time
`
`Further to the January 11, 2018 Scheduling Order (Paper 10), Petitioner and
`
`Patent Owner have agreed to extend Due Date 1 from April 11, 2018 to April 25,
`
`2018, and Due Date 2 from July 11, 2018 to July 25, 2018.
`
`Watson Laboratories, Inc. and United Therapeutics Corporation jointly
`
`request entry of the following revised schedule:
`
`DUE DATE 1 ............................................................................ Apr. 11, 2018
`
`Apr. 25, 2018
`
`Patent owner’s response to the petition
`Patent owner’s motion to amend the patent
`
`DUE DATE 2 ............................................................................. July 11, 2018
`
`July 25, 2018
`
`Petitioner’s reply to patent owner’s response to petition
`Petitioner’s opposition to motion to amend
`
`DUE DATE 3 ........................................................................... Aug. 13, 2018
`Patent owner’s reply to petitioner’s opposition to motion to amend
`
`DUE DATE 4 .............................................................................. Sep. 3, 2018
`Motion for observation regarding cross-examination of reply witness
`Motion to exclude evidence
`Request for oral argument
`
`DUE DATE 5 ............................................................................ Sep. 17, 2018
`Response to observation
`Opposition to motion to exclude
`
`1
`
`4824-8191-3696
`
`
`
`IPR2017-01622
`
`
`
`Joint Stipulation to Extend Time
`
`DUE DATE 6 ............................................................................ Sep. 24, 2018
`Reply to opposition to motion to exclude
`
`DUE DATE 7 ............................................................................... Oct. 9, 2018
`Oral argument (if requested)
`
`
`
`
`
`Respectfully submitted,
`
`Date: April 2, 2018
`
`
`/Michael K. Nutter/
`Michael K. Nutter (Reg. No. 44,979)
`WINSTON & STRAWN LLP
`35 W. Wacker Dr.
`Chicago, IL 60601
`
`Andrew R. Sommer (Reg. No. 53,932)
`WINSTON & STRAWN LLP
`1700 K Street, N.W.
`Washington, DC 20006-3817
`
`Kurt A. Mathas
`WINSTON & STRAWN LLP
`35 W. Wacker Dr.
`Chicago, IL 60601
`
`Counsel for Petitioner
`
`
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Registration No. 35,264
`
`George E. Quillin
`Registration No. 32,792
`
`Foley & Lardner LLP
`3000 K Street, N.W.
`Suite 600
`Washington, D.C. 20007
`
`Shaun R. Snader
`Registration No. 59,987
`
`United Therapeutics Corporation
`1735 Connecticut Avenue, N.W.
`Second Floor
`Washington, DC 20009
`
`Counsel for Patent Owner
`
`4824-8191-3696
`
`2
`
`
`
`IPR2017-01622
`
`
`
`Joint Stipulation to Extend Time
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing Joint Stipulation to
`
`Extend Time is being served on April 2, 2018, by filing this document through the
`
`PTAB E2E System as well as delivering copies via email to the following counsel
`
`for the Petitioner:
`
`Michael K. Nutter (Reg. No. 44,979)
`WINSTON & STRAWN LLP
`35 W. Wacker Dr.
`Chicago, IL 60601
`Email: mnutter@winston.com
`
`Andrew R. Sommer (Reg. No. 53,932)
`WINSTON & STRAWN LLP
`1700 K Street, N.W.
`Washington, DC 20006-3817
`Email: asommer@winston.com
`
`Kurt A. Mathas
`WINSTON & STRAWN LLP
`35 W. Wacker Dr.
`Chicago, IL 60601
`Email: kmathas@winston.com
`
`4824-8191-3696
`
`/Stephen B. Maebius/
`
`Stephen B. Maebius
`Registration No. 35,264
`
`George E. Quillin
`Registration No. 32,792
`
`Shaun R. Snader
`Registration No. 59,987
`
`Counsel for Patent Owner
`
`